Preferred Label : buflomedil;

MeSH note : RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure;

CISMeF synonym : 1A brand of buflomedil hydrochloride; AbZ brand of buflomedil hydrochloride; Buflo-POS; Buflo-Puren; LL 1656; abbott brand of buflomedil hydrochloride; alpharma brand of buflomedil hydrochloride; buflo 1A pharma; buflo AbZ; buflohexal; buflomedil heumann; buflomedil lindo; buflomedil pyridoxal phosphate; buflomedil stada; buflomedil von ct; buflomedil-ratiopharm; ct-Arzneimittel brand of buflomedil hydrochloride; fonzylane; heumann brand of buflomedil hydrochloride; hexal brand of buflomedil hydrochloride; hosbon brand of buflomedil hydrochloride; lafon brand of buflomedil hydrochloride; lindopharm brand of buflomedil hydrochloride; loftyl; ratiopharm brand of buflomedil hydrochloride; sinoxis; stadapharm brand of buflomedil hydrochloride; ursapharm brand of buflomedil hydrochloride;

MeSH synonym : 2,4,6-trimethoxyphenyl-3-pyrrolidine propyl ketone; bufomedil; blufomedil;

MeSH hyponym : Bufedil; Lofton;

MeSH CAS label : 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone;

MeSH Related Number : buflomedil hydrochloride; 35543-24-9 (HCl); 55837-25-7 (buflomedil); 35543-24-9 (buflomedil hydrochloride); 3J944AFS8S;

Registry Number MeSH : 55837-25-7;

Related CAS MeSH : 35543-24-9 (buflomedil hydrochloride);

related registry number list (CISMeF) : 35543-24-9 (HCl);

CISMeF hyponym : buflomédil chlorhydrate;

Codes EINECS : 259-851-3;

Is substance : O;

UNII : V7I71DQ432;

InChIKey : OWYLAEYXIQKAOL-UHFFFAOYSA-N;

Details


Main resources

You can consult :


http://www.cochrane.org/fr/CD009570/buflomedil-dans-le-traitement-de-laccident-vasculaire-cerebral-avc-ischemique-aigu
2015
false
false
false
France
United Kingdom
French
meta-analysis
stroke
brain ischemia
buflomedil
treatment outcome
cardiovascular agents
buflomedil
cardiovascular agents
french abstract
acute disease
buflomedil
buflomedil
pyrrolidines
pyrrolidines

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62991878
2012
France
summary of product characteristics
package leaflet
drug approval
buflomedil
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65902347
2012
France
summary of product characteristics
package leaflet
drug approval
tablets
buflomedil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64383376
2012
France
summary of product characteristics
package leaflet
buflomedil
tablets
drug approval

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62227072
2012
France
summary of product characteristics
package leaflet
buflomedil
tablets
drug approval

---
https://centres-antipoison.net/wp-content/uploads/2017/08/Rapport_CCTV_GT_Medicament_Buflomedil_Decembre_2011.pdf
2012
France
technical report
complement system proteins
report
buflomedil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61079012
2012
France
summary of product characteristics
package leaflet
tablets
buflomedil
drug approval

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69165431
2012
France
summary of product characteristics
package leaflet
tablets
drug approval
buflomedil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69899197
2012
France
summary of product characteristics
package leaflet
tablets
drug approval
buflomedil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64487713
2012
France
summary of product characteristics
package leaflet
tablets
drug approval
buflomedil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67937585
2012
France
summary of product characteristics
package leaflet
tablets
drug approval
buflomedil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68118585
2012
France
summary of product characteristics
package leaflet
buflomedil
drug approval
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65571616
2012
France
summary of product characteristics
package leaflet
drug approval
tablets
buflomedil

---
http://www.has-sante.fr/portail/jcms/c_1029063/fonzylane
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-03/fonzylane_-_ct-_10167.pdf
2011
France
French
administration, oral
treatment outcome
buflomedil
pyrrolidines
vasodilator agents
buflomedil
intermittent claudication
lower extremity
pyrrolidines
buflomedil
vasodilator agents
drug evaluation
insurance, health, reimbursement
pyrrolidines
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1061964/fonzylane-et-ses-generiques-buflomedil-vasodilatateur-synthese-d-avis
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-03/fonzylane_-_ct-_10167.pdf
2011
France
French
evaluation of the transparency committee
guidelines for drug use
drugs, generic
intermittent claudication
buflomedil
vasodilator agents
vasodilator agents
pyrrolidines
pyrrolidines
buflomedil
treatment outcome
risk assessment
administration, oral
buflomedil

---
http://www.cochrane.org/fr/CD000988
2009
United Kingdom
France
French
meta-analysis
intermittent claudication
treatment outcome
vasodilator agents
pyrrolidines
buflomedil
french abstract

---
https://centres-antipoison.net/wp-content/uploads/2017/08/Rapport_CCTV_Buflomedil_2009.pdf
2009
France
French
technical report
drug information
buflomedil
buflomedil
pyrrolidines
pyrrolidines
Drug-Related side effects and adverse reactions
administration, oral
Drug-Related side effects and adverse reactions
signs and symptoms
data collection
product surveillance, postmarketing
france
Drug-Related side effects and adverse reactions
suicide, attempted
medication errors
risk
risk management

---
https://www.minerva-ebp.be/fr/article/369
2008
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
arteritis
buflomedil
pyrrolidines
vasodilator agents
cardiovascular diseases

---
https://centres-antipoison.net/wp-content/uploads/2017/08/rapport_CCTV_Buflomedil_2008.pdf
2008
France
scientific and technical information
risk reduction
risk reduction behavior
risk management
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_432647
2006
France
evaluation of the transparency committee
buflomedil
tablets

---
http://www.has-sante.fr/portail/display.jsp?id=c_432656
2006
France
evaluation of the transparency committee
buflomedil
tablets

---
http://www.has-sante.fr/portail/display.jsp?id=c_432663
2006
France
evaluation of the transparency committee
tablets
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_432667
2006
France
evaluation of the transparency committee
tablets
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_432671
2006
France
evaluation of the transparency committee
buflomedil
tablets

---
http://www.has-sante.fr/portail/display.jsp?id=c_432675
2006
France
evaluation of the transparency committee
buflomedil
tablets

---
http://www.has-sante.fr/portail/display.jsp?id=c_432987
2006
France
evaluation of the transparency committee
tablets
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_432998
2006
France
evaluation of the transparency committee
buflomedil
injections

---
http://www.has-sante.fr/portail/display.jsp?id=c_432637
2006
France
evaluation of the transparency committee
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_433006
2006
France
evaluation of the transparency committee
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_433012
2006
France
evaluation of the transparency committee
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_438046
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032747.pdf
2006
France
French
pyrrolidines
buflomedil
administration, oral
infusions, parenteral
injections
vasodilator agents
adrenergic alpha-antagonists
buflomedil
treatment outcome
intermittent claudication
raynaud disease
ischemia
chronic disease
lower extremity
pyrrolidines
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_433019
2006
France
evaluation of the transparency committee
buflomedil
tablets

---
http://www.has-sante.fr/portail/display.jsp?id=c_433027
2006
France
evaluation of the transparency committee
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_433032
2006
France
evaluation of the transparency committee
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_432641
2006
France
evaluation of the transparency committee
tablets
buflomedil

---
http://www.has-sante.fr/portail/display.jsp?id=c_400087
2004
France
evaluation of the transparency committee
tablets
buflomedil

---
Nous contacter.
16/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.